StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

MIRM — Mirum Pharmaceuticals, Inc.

EXPENSIVE (MOS -40.8%) · Quality 0/100

Price
91.83
Intrinsic value
65.2
Margin of safety
-40.8%
Implied growth (reverse DCF)
+20.5%
model assumes +16.0%
Value Score
-5.6
Quality
0
Psychology
28.6
Discovery
30.2
price/volume attention only
Moat score
30
erosion: none

Value Score: bottom 1% of Russell 3000 · Quality: bottom 3%

Open the interactive Deep Dive for MIRM →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/MIRM - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is MIRM undervalued?

As of 2026-09-19, MIRM trades at 91.83 against a computed intrinsic value of 65.2 (-40.8% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Mirum Pharmaceuticals, Inc.'s Value Score?

Mirum Pharmaceuticals, Inc.'s Value Score is -5.6 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.